# Olive AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/olive-ai

- Industry: Software
- Headquarters: Columbus, US
- Website: www.oliveai.com
- Total disclosed funding: $835M
- Latest round: Series H (Jun 28, 2021)
- Investors on record: 17

## About

Founded in 2012 and based in Ohio, US, Olive AI, Inc. operates an AI-integrated online solution that helps in optimizing the workflow for the health industry. The company was founded by the CEO, Sean Lane, alongside Bradley Mascho. In July 2021, Olive AI, Inc. received its latest funding from investors Base10 Partners, Tiger Global Management, and Vista Equity Partners. In April 2021, the company acquired Empiric Health to strengthen its position in the market.

The company's product is an AI-integrated solution that optimizes the workflow for the health industry by providing solutions such as benefit & verification discovery, vendor contract management, invoice processing, inventory management, and periodic reporting.

## Funding rounds

- Series H, Jun 28, 2021, $450M — Vista Equity Partners, Tiger Global Management, Base10 Partners
- Series G, Nov 6, 2020, $226M — Hong Shan, General Catalyst Partners, Tiger Global Management, GV, Silicon Valley Bank, Drive Capital, Dragoneer Investment Group, Transformation Capital
- Series F, Oct 23, 2020, $46M — SVB Capital, General Catalyst Partners, Ascension Ventures, Drive Capital, Oak HC/FT
- Series E, Mar 30, 2020, $52M — General Catalyst Partners, Ascension Ventures, Drive Capital, Oak HC/FT
- Series D, Jul 16, 2018, $33M — Khosla Ventures, Ascension Ventures, Silicon Valley Bank, NCT Ventures, Drive Capital, Oak HC/FT, Moonshots Capital
- Series C, Mar 31, 2016, $15M — Khosla Ventures, Silicon Valley Bank, NCT Ventures, Drive Capital, Healthy Ventures, Moonshots Capital
- Series B, Apr 2, 2015, $7.6M — Khosla Ventures, Drive Capital
- Series A, Apr 4, 2013, $5M — Drive Capital

## Investors

- Drive Capital (https://capitalatlas.ai/funds/drive-capital) — Series A, Series B, Series C, Series D, Series E, Series F, Series G
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series B, Series C, Series D
- Silicon Valley Bank — Series C, Series D, Series G
- NCT Ventures (https://capitalatlas.ai/funds/nct-ventures) — Series C, Series D
- Healthy Ventures (https://capitalatlas.ai/funds/healthy-ventures) — Series C
- Moonshots Capital (https://capitalatlas.ai/funds/moonshots-capital) — Series C, Series D
- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Series D, Series E, Series F
- Oak HC/FT (https://capitalatlas.ai/funds/oak-hc-ft) — Series D, Series E, Series F
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series E, Series F, Series G
- SVB Capital (https://capitalatlas.ai/funds/svb-capital) — Series F
- Hong Shan — Series G
- Tiger Global Management (https://capitalatlas.ai/funds/tiger-global-management) — Series G, Series H
- GV (https://capitalatlas.ai/funds/gv) — Series G
- Dragoneer Investment Group (https://capitalatlas.ai/funds/dragoneer-investment-group) — Series G
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series G
- Vista Equity Partners (https://capitalatlas.ai/funds/vista-equity-partners) — Series H
- Base10 Partners (https://capitalatlas.ai/funds/base10-partners) — Series H